Abstract

A 68-year-old female was presented to the hospital with complainment of asthenicus for 2 months. Initial hematological results showed leukocyte of 80.26 × 109/L, hemoglobin of 134 g/L, and platelet of 401 × 109/L. Peripheral blood smear revealed 80% blast cells with small or medium size, and 27% blast cells with frequent cup-like nuclei (Figure 1A). Further bone marrow smear revealed hypercellular with 83% small- to medium-sized blast cells, and 10% blast cells with cup-like nuclei (Figure 1B). Myeloperoxidase (MPO) and nonspecific esterase were all negative. Further bone marrow immunophenotyping by flow cytometry were positive for CD34, CD19, HLA-DR, CD22, CD10, CD58, and cyCD79a on blast cells, but other myeloid and T-cell phenotype were negative. Then this patient was diagnosed with acute B-cell lymphoblastic leukemia (B-ALL). Furthermore, BCR-ABL1 p190 fusion gene was found in this patient, and 32 common lymphoid leukemia genes were sequenced and result showed the IKZF1 mutation (exon5, c.4.88A>G, p.His163Arg). Blasts with cup-like morphology are well recognized in acute myeloid leukemia (AML), being frequently associated with a normal karyotype and mutated NPM1 and/or FLT3-ITD. Recently, a novel association between cup-like nuclei and IKZF1 deletion in pediatric B-ALL had reported [1]. And these pediatric cup-like nuclei cases are more likely to have an early B-precursor phenotype, normal karyotype, or nonrecurrent cytogenetic abnormalities and are less likely to have favorable cytogenetic abnormalities [1]. Herein, we describe an unusual adult case of BCR-ABL1- p190 positive B-ALL with cup-like morphology. Whether this morphology of adult B-ALL patient is related to the BCR-ABL1 p190 and/or IKZF1 mutations needs further investigation. The authors would like to thank the encouragement and support of the members who take advanced study in the unit of cytology of the Department of Clinical Laboratory, Zhejiang Provincial People's Hospital. All authors reviewed this manuscript and agreed to submit this manuscript. The authors declare that they have no conflict of interest. Zhenni Wang and Xing Jin provide the picture and clinical data. Jinlin Liu analyzed the data and wrote the manuscript. This study has approved by the ethical committee of Zhejiang Provincial People's Hospital. This study did not involve the personal information, only report the laboratory data. Then the patient consent was waived, and this waive was approved by the ethical committee of Zhejiang Provincial People's Hospital. The authors received no funding for this article. Data are available on request from the authors.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.